Bio-Gene Technology Limited (ASX:BGT) Announces Positive Flavocide Efficacy Results
Bio-Gene Technology Limited (ASX:BGT) reports over 90% tick mortality with Flavocide, driving an 87% increase in its stock price.
Category: ASX-BGT
Bio-Gene Technology Limited
Bio-Gene Technology Limited (ASX:BGT) Launches Share Purchase Plan
Bio-Gene Technology Limited (ASX:BGT) launches a Share Purchase Plan (SPP) allowing shareholders to purchase up to $15,000 in shares with complimentary options.